Rua Bioscience Ltd banner

Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.033 NZD Market Closed
Market Cap: NZ$10.7m

Net Margin

-228.7%
Current
Improving
by 4 594.6%
vs 3-y average of -4 823.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-228.7%
=
Net Income
NZ$-3.5m
/
Revenue
NZ$1.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-228.7%
=
Net Income
NZ$-3.5m
/
Revenue
NZ$1.5m

Peer Comparison

Country Company Market Cap Net
Margin
NZ
Rua Bioscience Ltd
NZX:RUA
10.7m NZD
Loading...
US
Eli Lilly and Co
NYSE:LLY
995.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
573.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.7B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
CH
Novartis AG
SIX:NOVN
231.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.3B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
153B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD
Loading...

Market Distribution

Lower than 96% of companies in New Zealand
Percentile
4th
Based on 309 companies
4th percentile
-228.7%
Low
-2 988.2% — -2.1%
Typical Range
-2.1% — 9.4%
High
9.4% — 106.9%
Distribution Statistics
New Zealand
Min -2 988.2%
30th Percentile -2.1%
Median 4.2%
70th Percentile 9.4%
Max 106.9%

Rua Bioscience Ltd
Glance View

Market Cap
10.7m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.014 NZD
Overvaluation 57%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-228.7%
=
Net Income
NZ$-3.5m
/
Revenue
NZ$1.5m
What is Rua Bioscience Ltd's current Net Margin?

The current Net Margin for Rua Bioscience Ltd is -228.7%, which is above its 3-year median of -4 823.3%.

How has Net Margin changed over time?

Over the last 3 years, Rua Bioscience Ltd’s Net Margin has increased from -35 686% to -228.7%. During this period, it reached a low of -35 686% on May 30, 2022 and a high of -228.7% on Jul 30, 2025.

Back to Top